Remove Diabetes Remove Heart attacks Remove Research
article thumbnail

Research shows sotagliflozin is the first medication of its kind to significantly reduce both heart attacks and strokes

Medical Xpress - Cardiology

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart attack and stroke among these patients, according to results from an international clinical trial led by a Mount Sinai researcher.

article thumbnail

Researchers report clear shift in arterial diseases in diabetes

Medical Xpress - Cardiology

There has been a redistribution in the risk of arterial disease in type 1 and 2 diabetes. The risks of heart attack and stroke have decreased significantly, while complications in more peripheral vessels have increased in relative importance, according to studies at the University of Gothenburg.

article thumbnail

A diabetes, heart failure, and kidney disease medication is the first of its kind to significantly reduce both heart attacks and strokes

Science Daily - Heart Disease

New research shows sotagliflozin is the only drug in its class to demonstrate these results.

article thumbnail

Proposed risk factor tool finds heart failure rates are higher among American Indian adults

Science Daily - Heart Disease

An analysis based on a proposed heart failure risk prediction tool reveals that the incidence of heart failure may be 2- to 3-fold higher among American Indian adults compared to people in other population groups.

article thumbnail

Heart Disease and Stroke Could Affect at Least 60% of Adults in U.S. by 2050, According to American Heart Association Advisories

DAIC

Smith Center for Outcomes Research in Cardiology and director of the cardiac critical care unit at Beth Israel Deaconess Medical Center in Boston, Mass. Excluding people with high blood pressure, researchers project 15% of the population will have developed cardiovascular disease by 2050, up from 11.3% and Susan F. to 61% of the U.S.

article thumbnail

Minimal TV viewing may be protective for heart disease linked to type 2 diabetes, study finds

Medical Xpress - Cardiology

Watching no more than one hour of TV a day may lower the risk of heart attack, stroke and other blood vessel diseases among people with varying levels of genetic risk for type 2 diabetes, including high genetic risk, according to new research published in the Journal of the American Heart Association.

article thumbnail

Novel PCSK9 Inhibitor Cut LDL Cholesterol Levels by More Than Half

DAIC

milla1cf Sun, 04/07/2024 - 18:09 April 7, 2024 — Among patients at high or very high risk for a heart attack or stroke, the addition of the investigational drug lerodalcibep to standard cholesterol-lowering medication for one year reduced LDL, or “bad” cholesterol, levels by more than half on average, compared with a placebo.